ES526607A0 - Procedimiento de inmunoanalisis para determinar una droga antidepresiva triciclicar en una muestra de analisis liquida. - Google Patents

Procedimiento de inmunoanalisis para determinar una droga antidepresiva triciclicar en una muestra de analisis liquida.

Info

Publication number
ES526607A0
ES526607A0 ES526607A ES526607A ES526607A0 ES 526607 A0 ES526607 A0 ES 526607A0 ES 526607 A ES526607 A ES 526607A ES 526607 A ES526607 A ES 526607A ES 526607 A0 ES526607 A0 ES 526607A0
Authority
ES
Spain
Prior art keywords
triciclicar
immunoanalysis
procedure
analysis sample
liquid analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526607A
Other languages
English (en)
Other versions
ES8503133A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES8503133A1 publication Critical patent/ES8503133A1/es
Publication of ES526607A0 publication Critical patent/ES526607A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466—Antidepressants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES526607A 1982-10-21 1983-10-20 Procedimiento de inmunoanalisis para determinar una droga antidepresiva triciclicar en una muestra de analisis liquida. Granted ES526607A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/435,633 US4495281A (en) 1982-10-21 1982-10-21 Tricyclic antidepressant drug immunogens, antibodies, labeled conjugates, and related derivatives

Publications (2)

Publication Number Publication Date
ES8503133A1 ES8503133A1 (es) 1985-02-01
ES526607A0 true ES526607A0 (es) 1985-02-01

Family

ID=23729173

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526607A Granted ES526607A0 (es) 1982-10-21 1983-10-20 Procedimiento de inmunoanalisis para determinar una droga antidepresiva triciclicar en una muestra de analisis liquida.

Country Status (8)

Country Link
US (1) US4495281A (es)
EP (1) EP0107134B1 (es)
JP (1) JPS59132362A (es)
AU (1) AU554345B2 (es)
CA (1) CA1240986A (es)
DE (1) DE3362944D1 (es)
ES (1) ES526607A0 (es)
IL (1) IL69460A (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772697A (en) * 1983-08-01 1988-09-20 Syntex (U.S.A.) Inc. Tricylic antidepressant conjugates to antigens and enzymes
US4629691A (en) * 1983-08-01 1986-12-16 Syntex (U.S.A.) Inc. Tricyclic antidepressant conjugates with antigens and enzymes
US4606908A (en) * 1983-10-04 1986-08-19 Washington Research Foundation Methods and compositions for plasma and organ imaging
US4650771A (en) * 1983-11-04 1987-03-17 Miles Laboratories, Inc. Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof
FR2562671B1 (fr) * 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
US4795822A (en) * 1984-05-23 1989-01-03 Syntex (U.S.A.) Inc. Nortriptyline conjugates to antigenic proteins and enzymes
WO1991007661A1 (en) * 1989-11-20 1991-05-30 Hill Vincent E A method of detecting drugs in living and post-mortem skin and a kit therefor
GB9001694D0 (en) * 1990-01-25 1990-03-28 Therapeutic Antibodies Inc Immunogenic compositions
US5332661A (en) * 1991-07-31 1994-07-26 Abbott Laboratories Reagents and methods for the quantification of total doxepins in biological fluids
US5340750A (en) * 1991-07-31 1994-08-23 Abbott Laboratories Reagents and methods for the quantification of imipramine or desipramine in biological fluids
US5407835A (en) * 1991-07-31 1995-04-18 Abbott Laboratories Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
FR2692357A1 (fr) * 1992-06-12 1993-12-17 Centre Nat Rech Scient Antigène marqué par un système redox, procédé de dosage immunologique avec détection électrochimique et kit de dosage.
US6803040B1 (en) * 1995-08-22 2004-10-12 Biosite, Inc. Derivatives of tricyclic antidepressants and protein and polypeptide tricyclic antidepressant derivative conjugates and labels
IL131685A (en) * 1999-09-01 2007-03-08 Mordechai Erez Antiarrhythmic, antifbirillatory, and defibrillatory pharmaceutical compositions containing dibenzoazepines and dibenzodiazepines and same such novel compounds
US6368814B1 (en) * 2000-12-22 2002-04-09 Roche Diagnostics Corporation Tricyclic antidepressant derivatives and immunoassay
US8118991B2 (en) * 2001-09-04 2012-02-21 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US7166208B2 (en) * 2004-03-03 2007-01-23 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US9095572B2 (en) 2009-01-09 2015-08-04 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
US9162980B2 (en) 2009-01-09 2015-10-20 Board Of Regents Of The University Of Texas System Anti-depression compounds
US8362277B2 (en) 2009-01-09 2013-01-29 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
CN102405043B (zh) 2009-01-09 2017-08-22 得克萨斯州大学系统董事会 前神经原性化合物
FR2954700B1 (fr) * 2009-12-24 2012-02-03 Roquette Freres Utilisation de polysaccharides dans le traitement du stress et de l'anxiete
US9701676B2 (en) 2012-08-24 2017-07-11 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
WO2015070237A1 (en) 2013-11-11 2015-05-14 Board Of Regents Of The University Of Texas System Neuroprotective chemicals and methods for identifying and using same
US9902713B2 (en) 2013-11-11 2018-02-27 Board Of Regents Of The University Of Texas System Neuroprotective compounds and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
IN142734B (es) * 1975-04-28 1977-08-20 Miles Lab
US4043989A (en) * 1975-09-11 1977-08-23 Syva Company Oxazepam derivatives for immunoassay reagents
US4058511A (en) * 1976-01-12 1977-11-15 Syva Company Tegretol antigens and antibodies
US4279992A (en) * 1978-03-13 1981-07-21 Miles Laboratories, Inc. Specific binding assay employing an enzyme-cleavable substrate as label
US4213893A (en) * 1978-10-12 1980-07-22 Miles Laboratories, Inc. Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays
US4238565A (en) * 1978-06-22 1980-12-09 Miles Laboratories, Inc. Specific binding assay with a prosthetic group as a label component
US4223013A (en) * 1978-12-29 1980-09-16 Syva Company Amitriptyline conjugates to antigenic proteins and enzymes
US4275160A (en) * 1979-07-06 1981-06-23 Syva Company Imipramine derivatives and poly(amino acid) conjugates
US4288553A (en) * 1980-02-11 1981-09-08 Syva Company Disopyramide compounds for conjugating proteins used in immunoassays for disopyramide
US4446065A (en) * 1981-12-22 1984-05-01 Syva Company Phencyclidine compounds and assays for its determination

Also Published As

Publication number Publication date
IL69460A (en) 1986-11-30
ES8503133A1 (es) 1985-02-01
JPS59132362A (ja) 1984-07-30
EP0107134A1 (en) 1984-05-02
AU1787983A (en) 1984-05-03
IL69460A0 (en) 1983-11-30
AU554345B2 (en) 1986-08-14
JPH0231347B2 (es) 1990-07-12
US4495281A (en) 1985-01-22
EP0107134B1 (en) 1986-04-09
CA1240986A (en) 1988-08-23
DE3362944D1 (en) 1986-05-15

Similar Documents

Publication Publication Date Title
ES526607A0 (es) Procedimiento de inmunoanalisis para determinar una droga antidepresiva triciclicar en una muestra de analisis liquida.
ES523242A0 (es) "procedimiento de obtencion de un elemento analitico para determinar un analito en una muestra liquida".
ES517080A0 (es) Procedimiento de inmunoanalisis para determinar una iodotironina en una muestra de analisis.
ES513750A0 (es) Procedimiento de obtencion de elementos analiticos de capas multiples para detectar un ligando en una muestra liquida.
ES525861A0 (es) Procedimiento de inmunoanalisis para determinar digoxina en una muestra de analisis.
ES490057A0 (es) Procedimiento y sistema para separar componentes sanguineos contenidos en una muestra de sangre
ES495936A0 (es) Un metodo para detectar la presencia de un material analiza-ble en una muestra
ES497802A0 (es) Procedimiento para detectar sustancias peroxidativamente activas en una muestra.
MX150953A (es) Mejoras en recipiente para muestra liquida fisiologica
ES516043A0 (es) "perfeccionamientos en un conjunto de aguja para recoger una o mas muestras de liquido".
ES507948A0 (es) Procedimiento y dispositivo de analisis simultaneo, especialmente para analisis clinicos. otrosi.
ES524166A0 (es) Perfeccionamientos en un aparato para medir parametros cineticos en una reaccion de un analizado con un reactivo especifico
MX144456A (es) Mejoras en sistema automatico para analisis de sangre
BR8202753A (pt) Conjunto de agulha para amostras multiplas para determinar penetracao na veia
ES513099A0 (es) "un metodo con su aparato correspondiente para medir el tiempo de coagulacion de una muestra de sangre".
ES508096A0 (es) Dispositivo de deteccion de hidrogeno para determinar la concentracion de hidrogeno en una atmosfera liquida.
MX153322A (es) Dispositivo analitico quimioluminiscente mejorado para detectar un componente en una muestra de liquidos corporales
ES497544A0 (es) Un metodo para detectar sangre oculta en un especimen huma- no.
ES497804A0 (es) Procedimiento para detectar sustancias peroxidativamente activas en una muestra.
ES489644A0 (es) Un metodo de determinar la cantidad o concentracion de un analito en una muestra
ES501734A0 (es) Un procedimiento para la deteccion de anticuerpos en una muestra de ensayo
IT1063192B (it) Dispositivo per l analisi dei costituenti di una soluzione mediante determinazione fotometrica
ES498753A0 (es) Una disposicion de aguja con valvula para la toma de multi- ples muestras.
MX148001A (es) Mejoras en aparato para detectar la presencia de una substancia sobre una superficie liquida
ES497803A0 (es) Procedimiento para detectar sustancias peroxidativamente activas en una muestra.